marking the fourth consecutive day the stock has increased. Some of the biggest losers among healthcare stocks include: Aegerion Pharmaceuticals (AEGR): AEGR stock is down 21.6% today on 8 times normal volume. Acadia Healthcare …
but if investors have been misled and the number is actually 90% less, what will we value AEGR's stock price with a U.S. patient population of only 300? Here is a claim made in the third quarter conference call: "… I would emphasize that …
(Editor’s note: Corrected to show Chimerix’s stock offering involves existing shares ... It was unclear what drove the drop for Aegerion /quotes/zigman/624094 /quotes/nls/aegr AEGR, which plunged more than 10% to $76.42 at the close.
Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR) engages in the development and commercialization ... Aegerion closed Monday at $56.74. The stock is down more than 20% since the beginning of the year. Best Buy Co. Inc. (NYSE: BBY) …
One name in particular that got drilled viciously was Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR). The company posted a huge earnings miss and offered less than stellar guidance. To make things worse, the company’s stock was …
Some of the biggest gainers among healthcare stocks include: Ptc Therapeutics Inc (PTCT): PTCT stock is up 5.7% today and up 24.8% in the last month. Aegerion Pharmaceuticals (AEGR): AEGR stock is up 3.7% today. Brookdale Senior …
Marc Beer, the CEO of Aegerion Pharmaceuticals ( AEGR), bought 10,000 shares of the company's common stock on May 27. At 31.59 per share, Beer paid a total of $315,900 for the new shares. IK-> The technicals for AEGR ($32.73 up …
Aegerion Pharmaceuticals (AEGR) was a big mover last session, as its shares rose over 5% on the day. The rise came on solid volume too with far more shares changing hands than in a normal session. This reverses the recent trend for the …
Aegerion Pharmaceuticals Inc. (NASDAQ: AEGR) should have a slogan that says “We love volatility.” The biotech stock now trades for just under $60 after its earnings report, but the 52-week trading range is $29.61 to $101.00. After a poor …
AEGR), a biopharmaceutical company dedicated to the development and commercialization of innovative therapies for patients with debilitating rare diseases, today announced that on October 1, 2014, Aegerion granted stock options to …